Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDACADIA Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 8 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2025 | 6 | $0.14 | $0.17 | $0.16 |
| Q3 2025 | 4 | $0.17 | $0.20 | $0.18 |
| Q4 2025 | 6 | $0.19 | $0.22 | $0.21 |
| Q1 2026 | 3 | $0.19 | $0.23 | $0.21 |
| Q2 2026 | 5 | $0.22 | $0.26 | $0.24 |
| Q3 2026 | 3 | $0.16 | $0.18 | $0.17 |
| Q4 2026 | 5 | $0.27 | $0.31 | $0.29 |
ACADIA Pharmaceuticals Inc. Earnings Date And Information
ACADIA Pharmaceuticals Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.04. The company had revenue of 259.60 M for the quarter and had revenue of 957.80 M for the year. ACADIA Pharmaceuticals Inc. has generated $1 earnings per share over the last year ($1.36 diluted earnings per share) and currently has a price-to-earnings ratio of 12.27. ACADIA Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
ACADIA Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | N/A | $0.87 | N/A | $255.61 M | $259.60 M |
| 11/06/2024 | Q3 2024 | N/A | $0.20 | N/A | $248.83 M | $250.40 M |
| 08/06/2024 | Q2 2024 | N/A | $0.20 | N/A | $235.95 M | $241.96 M |
| 05/08/2024 | Q1 2024 | N/A | $0.10 | N/A | N/A | $205.83 M |
| 12/30/2023 | Q4 2023 | N/A | $0.28 | N/A | $223.79 M | $231.04 M |
| 11/02/2023 | Q3 2023 | N/A | -$0.40 | N/A | $192.32 M | $211.70 M |
| 08/02/2023 | Q2 2023 | N/A | $0.01 | N/A | $166.18 M | $165.24 M |
| 05/08/2023 | Q1 2023 | -$0.21 | -$0.27 | -0.06 | N/A | $118.46 M |
| 02/27/2023 | Q4 2022 | N/A | -$0.26 | N/A | N/A | $136.49 M |
| 11/02/2022 | Q3 2022 | N/A | -$0.17 | N/A | $138.76 M | $130.71 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.21 | N/A | $130.41 M | $134.56 M |
| 05/04/2022 | Q1 2022 | N/A | -$0.70 | N/A | N/A | $115.47 M |
| 03/01/2022 | Q4 2021 | N/A | -$0.27 | N/A | N/A | $130.76 M |
| 11/08/2021 | Q3 2021 | N/A | -$0.09 | N/A | $127.93 M | $131.61 M |
| 08/04/2021 | Q2 2021 | N/A | -$0.27 | N/A | $124.90 M | $115.22 M |
| 05/05/2021 | Q1 2021 | N/A | -$0.42 | N/A | N/A | $106.55 M |
| 02/24/2021 | Q4 2020 | N/A | -$0.42 | N/A | N/A | $121.01 M |
| 11/04/2020 | Q3 2020 | -$0.38 | -$0.54 | -0.16 | $118.82 M | $120.58 M |
| 08/05/2020 | Q2 2020 | N/A | -$0.27 | N/A | $103.41 M | $110.10 M |
| 05/07/2020 | Q1 2020 | N/A | -$0.57 | N/A | N/A | $90.07 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ACADIA Pharmaceuticals Inc. Earnings: FAQ's
ACADIA Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based offlast year's report dates.
In the previous quarter, ACADIA Pharmaceuticals Inc. (:ACAD) reported $0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $0.13 by $0.04.
The conference call for ACADIA Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for ACADIA Pharmaceuticals Inc.'s latest earnings report can be read online.
ACADIA Pharmaceuticals Inc. (:ACAD) has a recorded annual revenue of $957.80 M.
ACADIA Pharmaceuticals Inc. (:ACAD) has a recorded net income of $226.45 M.ACADIA Pharmaceuticals Inc. has generated $1.37 earnings per share over the last four quarters.
ACADIA Pharmaceuticals Inc. (:ACAD) has a price-to-earnings ratio of 12.27 and price/earnings-to-growth ratio is 0.16.